XFOR short interest
X4 Pharmaceuticals Inc. · Healthcare · Biotechnology · settlement date 2026-09-30
| Shares short | 7,590,000 |
|---|---|
| Change vs prior report | -646,475 (-7.8%) |
| Change over six months | +143.0% |
| Days to cover | 6.04 (sector: 3.78) |
| Average daily volume | 1,256,869 |
| Rank in Healthcare | #319 of 922 by days to cover |
XFOR short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 7,590,000 | -7.8% | 6.04 | 1,256,869 |
| 2026-09-15 | 8,236,475 | +14.6% | 7.07 | 1,164,513 |
| 2026-08-31 | 7,190,058 | +0.3% | 12.84 | 560,027 |
| 2026-08-14 | 7,164,662 | -1.9% | 8.92 | 803,567 |
| 2026-07-31 | 7,300,120 | +12.3% | 12.75 | 572,776 |
| 2026-07-15 | 6,501,966 | +18.1% | 9.79 | 663,901 |
| 2026-06-30 | 5,507,057 | +31.7% | 3.47 | 1,586,041 |
| 2026-06-15 | 4,180,487 | +24.0% | 9.92 | 421,393 |
| 2026-05-29 | 3,371,418 | +15.3% | 9.28 | 363,115 |
| 2026-05-15 | 2,923,580 | -6.2% | 8.49 | 344,226 |
| 2026-04-30 | 3,117,372 | -0.9% | 8.35 | 373,452 |
| 2026-04-15 | 3,144,815 | +0.7% | 7.58 | 414,981 |
| 2026-03-31 | 3,123,686 | -10.7% | 7.16 | 436,290 |
| 2026-03-13 | 3,498,089 | +1.2% | 5.65 | 619,124 |
| 2026-02-27 | 3,456,380 | +2.3% | 6.15 | 561,715 |
| 2026-02-13 | 3,379,356 | +8.2% | 6.51 | 518,827 |
| 2026-01-30 | 3,121,800 | +0.9% | 12.59 | 248,022 |
| 2026-01-15 | 3,094,769 | +3.1% | 7.32 | 422,814 |
| 2025-12-31 | 3,001,615 | -4.9% | 2.92 | 1,027,887 |
| 2025-12-15 | 3,155,605 | +27.1% | 4.22 | 747,734 |
| 2025-11-28 | 2,482,029 | +27.8% | 5.09 | 487,977 |
| 2025-11-14 | 1,942,100 | +30.1% | 3.47 | 559,677 |
| 2025-10-31 | 1,492,168 | -16.4% | 1.00 | 2,427,246 |
| 2025-10-15 | 1,785,248 | -12.8% | 4.57 | 390,222 |
| 2025-09-30 | 2,047,594 | +8.2% | 4.73 | 433,130 |
import finzdata as yf
yf.Ticker("XFOR").short_interest # every report since 2017
yf.Client().short_interest(["XFOR"], start="2018-01-01")Healthcare short interest · XFOR price history · Who owns XFOR · All short interest